Dr. Ronan Glynn:

To build on that very briefly, I would simply point people back to a previously released report. We have had discussions among the membership of NPHET this morning, but of course there is a very wide membership on the Health Information and Quality Authority, HIQA, expert advisory group, which also feeds in with a range of expertise. I would point people back to its report in September. Many of the key findings of that report still hold true.

Ultimately, we have said all along that antigen testing was most appropriate in high-prevalence settings, outbreak situations or where PCR testing capacity was constrained. All of those scenarios played out over recent weeks, which led to the recommendations that were made on antigen testing. However, the underpinning advice on the use of that modality has not changed over time.